Literature DB >> 20926565

Immature and transitional B cells are latency reservoirs for a gammaherpesvirus.

Carrie B Coleman1, Michael S Nealy, Scott A Tibbetts.   

Abstract

Gammaherpesviruses, including Kaposi's sarcoma-associated herpesvirus (KSHV; also known as human herpesvirus 8 [HHV-8]), Epstein-Barr virus (EBV), and murine gammaherpesvirus 68 (MHV68; also known as gammaherpesvirus 68 [γHV68] or murine herpesvirus 4 [MuHV-4]), establish lifelong latency in the resting memory B cell compartment. However, little is known about how this reservoir of infected mature B cells is maintained for the life of the host. In the context of a normal immune system, the mature B cell pool is naturally maintained by the renewable populations of developing B cells that arise from hematopoiesis. Thus, recurrent infection of these developing B cell populations could allow the virus continual access to the B cell lineage and, subsequent to differentiation, the memory B cell compartment. To begin to address this hypothesis, we examined whether MHV68 establishes latency in developing B cells during a normal course of infection. In work described here, we demonstrate the presence of viral genome in bone marrow pro-pre-B cells and immature B cells during early latency and immature B cells during long-term latency. Further, we show that transitional B cells in the spleen are latently infected and express the latency-associated nuclear antigen (LANA) throughout chronic infection. Because developing B cells normally exhibit a short life span and a high rate of turnover, these findings suggest a model in which gammaherpesviruses may gain access to the mature B cell compartment by recurrent seeding of developing B cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20926565      PMCID: PMC3004345          DOI: 10.1128/JVI.01455-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

Review 1.  Epstein-Barr virus: exploiting the immune system.

Authors:  D A Thorley-Lawson
Journal:  Nat Rev Immunol       Date:  2001-10       Impact factor: 53.106

2.  Effective vaccination against long-term gammaherpesvirus latency.

Authors:  Scott A Tibbetts; J Scott McClellan; Shivaprakash Gangappa; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

3.  Use of a virus-encoded enzymatic marker reveals that a stable fraction of memory B cells expresses latency-associated nuclear antigen throughout chronic gammaherpesvirus infection.

Authors:  Michael S Nealy; Carrie B Coleman; Haiyan Li; Scott A Tibbetts
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

4.  Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice.

Authors:  R G Caldwell; R C Brown; R Longnecker
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation.

Authors:  D Allman; R C Lindsley; W DeMuth; K Rudd; S A Shinton; R R Hardy
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

6.  Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis.

Authors:  R J Risdall; R W McKenna; M E Nesbit; W Krivit; H H Balfour; R L Simmons; R D Brunning
Journal:  Cancer       Date:  1979-09       Impact factor: 6.860

7.  Differential gamma-herpesvirus distribution in distinct anatomical locations and cell subsets during persistent infection in mice.

Authors:  Emilio Flaño; In-Jeong Kim; John Moore; David L Woodland; Marcia A Blackman
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

8.  Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus.

Authors:  Scott A Tibbetts; Linda F van Dyk; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

9.  Establishment and maintenance of gammaherpesvirus latency are independent of infective dose and route of infection.

Authors:  Scott A Tibbetts; Joy Loh; Victor Van Berkel; James S McClellan; Meagan A Jacoby; Sharookh B Kapadia; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

10.  Selective gene expression of latent murine gammaherpesvirus 68 in B lymphocytes.

Authors:  Sofia Marques; Stacey Efstathiou; K G Smith; Matthias Haury; J Pedro Simas
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

View more
  32 in total

1.  Tiled microarray identification of novel viral transcript structures and distinct transcriptional profiles during two modes of productive murine gammaherpesvirus 68 infection.

Authors:  Benson Yee Hin Cheng; Jizu Zhi; Alexis Santana; Sohail Khan; Eduardo Salinas; J Craig Forrest; Yueting Zheng; Shirin Jaggi; Janet Leatherwood; Laurie T Krug
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

2.  B Cell-Specific Expression of Ataxia-Telangiectasia Mutated Protein Kinase Promotes Chronic Gammaherpesvirus Infection.

Authors:  Eric J Darrah; Joseph M Kulinski; Wadzanai P Mboko; Gang Xin; Laurent P Malherbe; Stephen B Gauld; Weiguo Cui; Vera L Tarakanova
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

3.  ATM facilitates mouse gammaherpesvirus reactivation from myeloid cells during chronic infection.

Authors:  Joseph M Kulinski; Eric J Darrah; Katarzyna A Broniowska; Wadzanai P Mboko; Bryan C Mounce; Laurent P Malherbe; John A Corbett; Stephen B Gauld; Vera L Tarakanova
Journal:  Virology       Date:  2015-05-21       Impact factor: 3.616

4.  Host Tumor Suppressor p18INK4c Functions as a Potent Cell-Intrinsic Inhibitor of Murine Gammaherpesvirus 68 Reactivation and Pathogenesis.

Authors:  Brian F Niemeyer; Lauren M Oko; Eva M Medina; Darby G Oldenburg; Douglas W White; Carlyne D Cool; Eric T Clambey; Linda F van Dyk
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

Review 5.  Gammaherpesviruses and B Cells: A Relationship That Lasts a Lifetime.

Authors:  Kaitlin E Johnson; Vera L Tarakanova
Journal:  Viral Immunol       Date:  2020-01-08       Impact factor: 2.257

6.  Tumor Suppressor Interferon-Regulatory Factor 1 Counteracts the Germinal Center Reaction Driven by a Cancer-Associated Gammaherpesvirus.

Authors:  Wadzanai P Mboko; Horatiu Olteanu; Avijit Ray; Gang Xin; Eric J Darrah; Suresh N Kumar; Joseph M Kulinski; Weiguo Cui; Bonnie N Dittel; Stephen B Gauld; Vera L Tarakanova
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

7.  Efficient infection of a human B cell line with cell-free Kaposi's sarcoma-associated herpesvirus.

Authors:  Stephen J Dollery; Rey J Santiago-Crespo; Lela Kardava; Susan Moir; Edward A Berger
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

8.  Retention of anergy and inhibition of antibody responses during acute γ herpesvirus 68 infection.

Authors:  Andrew Getahun; Mia J Smith; Igor Kogut; Linda F van Dyk; John C Cambier
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

9.  Identification of alternative transcripts encoding the essential murine gammaherpesvirus lytic transactivator RTA.

Authors:  Brian S Wakeman; L Steven Johnson; Clinton R Paden; Kathleen S Gray; Herbert W Virgin; Samuel H Speck
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

10.  Systemic and local infection routes govern different cellular dissemination pathways during gammaherpesvirus infection in vivo.

Authors:  Aurore Vidy; Torsten Sacher; Heiko Adler; Stefan Jordan; Ulrich H Koszinowski; Zsolt Ruzsics
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.